Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 37

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 37
---
 would otherwise apply to private companies. We have elected to avail ourselves of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the dates on which adoption of such standards is required for other public reporting companies. We are also a “smaller reporting company” as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and have elected to take advantage of certain of the scaled disclosure available for smaller reporting companies. We will remain a smaller reporting company until the end of the fiscal year in which (1) we have a public common equity float of more than $250 million, or (2) we have annual revenues for the most recently completed fiscal year of more than $100 million and a public common equity float or public float of more than $700 million. We also would not be eligible for status as a smaller reporting company if we become an investment company, an asset-backed issuer or a majority-owned subsidiary of a parent company that is not a smaller reporting company. We have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different from what you might receive from other public reporting companies in which you hold equity interests.

<div align='center'>16</div>

SUMMARY OF THE OFFERING

| Securities offered by us                                  |     | 1,753,314 shares of common stock and 878,264 Pre-Funded Warrants and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 accompanying Series A-1 Warrants to purchase up to an aggregate of 2,631,578 shares of common stock and Series A-2 Warrants to purchase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 up to an aggregate of 2,631,578 shares of common stock. The shares of common stock, or Pre-Funded Warrants in lieu thereof, and in each                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 case the accompanying Warrant, will be separately transferable immediately upon issuance.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Pre-Funded Warrants offered by us                         |     | The Pre-Funded Warrants are being sold to purchasers whose purchase                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 of shares of common stock in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 beneficially owning more than 4.99